Location History:
- Shanghai, CN (2013)
- Shanghai, IN (2015)
Company Filing History:
Years Active: 2013-2015
Title: Innovator in Tumor Treatment: The Contributions of Zhende Liu
Introduction: Zhende Liu, an accomplished inventor based in Shanghai, Indiana, has made significant strides in the field of medicinal chemistry. With two patented inventions, Liu is dedicated to developing innovative solutions for combating tumors, specifically targeting liver cancer.
Latest Patents: Liu's latest patents focus on the advancements of pyridazinones, a class of compounds with notable therapeutic potential. His first patent, "Substituted pyridazinones for the treatment of tumors," details a method for preparing a specific pyridazinone derivative—6-[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one. This compound serves as a mother nucleus, highlighting its utility in the manufacturing of medicaments aimed at treating tumors, particularly in the liver. In his second patent, "Derivatives of 6-[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity," Liu further explores and elaborates on the potential antitumor activities of this compound and its derivatives.
Career Highlights: Zhende Liu is affiliated with the Chinese Academy of Sciences, where he continues to contribute to advanced research in pharmaceuticals. His work focuses on devising new strategies for the development of effective cancer treatments. His contributions underscore the importance of innovative research in the fight against cancer.
Collaborations: Throughout his career, Liu has collaborated with esteemed colleagues, including Youhong Hu and Liguang Lou. These collaborations assist in enhancing the research and development process, promoting a shared goal of discovering impactful treatments for cancer patients.
Conclusion: Zhende Liu’s innovative work at the Chinese Academy of Sciences, particularly in the realm of pyridazinones for tumor treatment, illustrates the vital role of inventors in advancing medical science. With his ongoing contributions to research and patent development, Liu stands at the forefront of innovation in cancer therapeutics, promising a brighter future for treatment options against liver cancer.